Josh Halpern, IntegriChain’s co-founder and executive vice president, notes that Datavant’s extensive provider network helps simplify the patient experience in a secure manner.
“Datavant has developed an unrivaled network of data providers that are utilizing its tokenization technology,” he said. “We’re excited to offer our life sciences customers new ways to compliantly and securely integrate their ecosystems of patient-level data assets, while also gaining better control over integration quality. Patient mastering is the single most important requirement for aggregation quality, and Datavant gives us new ways to ensure the accuracy of specialty patient journey analytics.”
In October 2020, IntegriChain introduced GTN (gross-to-net) Analytics, a service for life sciences manufacturers to improve visibility to the market access datasets that power the accuracy of accruals and forecasting processes.
The post IntegriChain and Datavant reach patient visibility agreement appeared first on Pharmaceutical Commerce.